Keywords
Cardiovascular system
Cardiovascular disease
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Analyze and correlate the cardiovascular impact of COVID-19 in pacients with comorbities and risk factor associated with the damage caused by the infection, as well as prognosis and the relation with mortality. Methods: This is an integrative review of the literature, with articles published between 2020 and 2023, including observational studies and clinical trials with full text available. The search was carried out in the following databases: National Libery of Medicine (Pubmed) and VHL Regional Portal. As descriptors in the search for articles, the following were used: ´´Covid-19´´, impact ´´, ´´cardiovascular system´´, associated with the Boolerian operator ´´AND´´. Results: 11 articles were selected from the Pubmed database and 8 articles from the VHL regional portal, with 6 articles being removed from this study due to being duplicated between platforms, resulting in 19 articles. Final considerations: In conclusion, It is important that healthcare professionals know how to identify and manage cardiac changes during the course of COVID-19, due to their impact on the cardiovascular system and mortality.Therefore, It is important that healthcare professionals know how to identify and manage cardiac changes during the course of COVID-19, due to their impact on the cardiovascular system and mortality.
References
ÁGUILA-GORDO D. et al. Enfermedad cardiovascular tras infección por SARS-CoV-2 en pacientes ancianos. Resultados del seguimiento anual de una cohorte de supervivientes. Revista Española de Geriatría y Gerontología, 2021; 57(2): 100–104.
ALEKSOVA A, et al. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. International Journal of Molecular Sciences, 2021; 22(9): 4526-4540.
ANALIS A, et al. COVID-19 infection and cardiac arrhythmias. Trends in Cardiovascular Medicine, 2020; 30(8): 451-460.
ARABADJIAN M, et al. COVID-19 in Adults With Hypertrophic Cardiomyopathy. Directory of Open Acces Journals, 2021; 8.
AZEVEDO R, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension, 2020; 35(1): 4-11.
BOURGONJE AR, et al. Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). The Journal of Pathology, 2020; 251(3): 228-248.
CARO-CODÓN J, et al. Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients. Revista Portuguesa de Cardiologia. 2022; 41(10): 823-830.
CHEN Q, et l. Cardiovascular manifestations in severe and critical patients with COVID ‐19. Clinical Cardiology. 2020; 43(7): 796-802.
CONNORS JM e LEVY JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23): 2033-2040.
COSTA I, et al. Cardiovascular imaging and interventional procedures in patients with novel Coronavirus in infection. Arquivos brasileiros de cardiologia. 2020; 115(1): 111-116.
DA SILVA SJR. et al. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infectious Diseases. 2022; 8(9): 1758-1814.
DEUEL JW. et al. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo). The Lancet Infectious Diseases. 2022; 22(12): 1694-1702.
DIAZ-AROCUPITA C, et al. Pericarditis in patientes whit COVID-19: a sistematic review. Journal of Cardiovascular Medicine. 2021; 22(9): 693-700.
GARCIA S, et al. Initial Findings from the North America COVID-19 Myocardical infarction Registry. Journal of American College of Cardiology. 2021; 77: 1994-2003.
HUANG N, et al. Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in Eats-Asian patients with COVID-19. 2023; 18(1): 0280280.
KHAWAJA S, et al. COVID-19 And Its impacto n the cardiovascular system. Open Heart. 2021; 8(1): 001472.
KINI A, et al. Types of myocardial injury and mid – term outcomes in patients whit COVID-19. European Heart Journal-Quality of care clinical outcomes. 2021; 7(5): 438-446.
KUNAL S, et al. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart Journal. 2020; 72(6): 593-598.
LAÍREZ O, et al. Cardiac imagingphenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study. International Journalof Cardiovascular Imaging. 2021; 37(2): 449-457.
MAGALHÃES BK, et al. The impact of chronic cardiovascular disease on COVID-19 clinical course. Journal of clinical and translational research. 2022; 8(4): 308-322.
MALATY M, et al. Incidence and treatmen of arrhythmias secundary to coronavirua infection in humans: A systematic review. European Journal of Clinical Investigation. 2020; 51(2): 13428.
MANCIA G, et al. Renin-Angiotensin-Aldosterone System Blockers and the risk of COVID-19. New England Journal of Medicine. 2020; 385(25): 2431-2440.
MARFELLA R, et al. SARS-COV-2 colonizes coronary thrombus and impairs heart micro circulation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. CriticalCare. 2021; 25(1): 217-229.
NAGY É, et al. The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients—A Retrospective Study in a Hungarian Hospital. International Journal of Environmental Research and Public Health. 2023; 20(2): 1372-1387.
OLIVEIRA GMM, et al. Estatística Cardiovascular – Brasil 2021. Arq. Bras. Cardiol. 2022; 118(1): 115-373.
PARK B, et al. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. Journal of Korean Medical Science. 2021; 6(2): 15.
RUSSO V, et al. Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study. European Journal of Clinical Investigation. 2020; 50(12): 13387.
SAEED S, et al. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pakistan Journal of Medical Sciences. 2021; 37(3): 908-912.
SANZ A, et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiology Journal2020. 2021; 28(1): 34-40.
SATO K, et al. Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study. BMC Cardiovascular Disorders. 2022; 22(1): 132-144.
SHARMA, A, et al. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2020; 13(2): 202.
SHEEHAN M, et al. Echocardiography in suspected corona vírus infection: indications, limitations and impact on clinical management. Open Heart. 2021; 8(2): 001702.
SOUZA, ASR. et al. Aspectos gerais da pandemia de COVID-19. Revista Brasileira de Saúde Materno Infantil. 2021; 21(1): 29-45.
VILLALBA G, et al. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiology Journal. 2021; 28(3): 960-368.
YE Z, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension. 2020; 30(8): 4381-1389.